RxDoctor Payments Data

Pugazhendhi Vijayaraman, MD

Clinical Cardiac Electrophysiology · Wilkes Barre, PANPI 1669422184

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $368,949 of the $593,895 with a category attached, or 62.1%. Medtronic accounts for 73.5% of it on its own, with 10 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$593,895in general payments, 2019–2025

Across 588 payments — averaging $1010.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$436K
  • Biotronik Inc.$56K
  • Abbott$44K
  • Boston Scientific$38K
  • Biosense Webster, Inc.$10K
  • Medical Device Business Services, Inc.$5K
  • plus $4K from 5 others
$653,611in research payments, 2019–2025

Across 590 payments — averaging $1107.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$422K
  • Abbott$124K
  • Biotronik Inc.$107K

What the payments were for

  • Consulting fees$115,72819%
  • Speaking & faculty fees$368,94962%
  • Grants$9,7642%
  • Travel & lodging$84,98914%
  • Food & beverage$14,4642%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$593,895 in reported general payments places this provider in the 95th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$208,415
Medicare patients
1,142
Services billed
2,776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$25,357
Flecainide Acetate16$1,242
Amiodarone Hcl18$331
Metoprolol Succinate17$218
Warfarin Sodium11$172
Metoprolol Tartrate15$62

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Wilkes Barre

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →